Decoding colorectal cancer lung metastasis: a global research odyssey
- PMID: 40777130
- PMCID: PMC12328170
- DOI: 10.3389/fonc.2025.1587422
Decoding colorectal cancer lung metastasis: a global research odyssey
Abstract
Background: Colorectal cancer (CRC) remains a major global health burden, particularly when complicated by pulmonary metastasis (PM), which significantly worsens prognosis and reduces survival despite active treatment. The absence of standardized therapeutic strategies for CRC with PM has driven research into its underlying biological mechanisms, including epithelial-mesenchymal transition, immune evasion, and tumor microenvironment dynamics.
Methods: A bibliometric analysis was conducted on 2,645 publications related to CRC with PM retrieved from the Web of Science Core Collection (1991-2025). Analytical tools such as CiteSpace and VOSviewer were employed to map the intellectual structure, collaboration networks, and research hotspots within this domain.
Results: The analysis identified China and Japan as the most prolific countries in CRC-PM research, with Robert M. Hoffman (USA) and David L. Morris (Australia) as the most productive authors, and Joachim Pfannschmidt (Germany) as the most frequently cited. Annals of Surgery was recognized as the most influential journal. Four primary research themes were identified: (1) molecular mechanisms underlying CRC lung metastasis, (2) surgical intervention strategies, (3) systemic therapies and clinical trials, and (4) clinical management and outcome evaluation. These studies reflect a growing emphasis on multidisciplinary approaches and translational research.
Conclusion: The field has witnessed notable progress in multimodal treatment strategies, encompassing advances in surgical techniques, chemotherapy regimens, and targeted therapies, all of which have contributed to improved patient assessment and survival outcomes. Future research should focus on optimizing integrated therapeutic approaches and refining clinical management protocols to further improve outcomes for patients with CRC and pulmonary metastases.
Keywords: bibliometric analysis; colorectal cancer; molecular mechanisms; pulmonary metastases; surgical treatment.
Copyright © 2025 Zhang, Wang, Fu, Duan, Wang, Chen and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
Driving innovations in cancer research through spatial metabolomics: a bibliometric review of trends and hotspot.Front Immunol. 2025 Jun 10;16:1589943. doi: 10.3389/fimmu.2025.1589943. eCollection 2025. Front Immunol. 2025. PMID: 40557160 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w. Online ahead of print. Updates Surg. 2025. PMID: 40580377
-
Advances and frontiers in pulmonary fibrosis and lung cancer research (2000-2024): a bibliometric analysis.Front Med (Lausanne). 2025 Jun 23;12:1596228. doi: 10.3389/fmed.2025.1596228. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40625354 Free PMC article.
References
LinkOut - more resources
Full Text Sources